Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
6: Cancer
| Question | Answer |
|---|---|
| adenocarcinoma | cancers of glandular epithelial cells |
| adenomatous polyposis coli (APC) | a dominant tumor suppressor gene on chromosome 5. Mutations of APC are associated with familial adenomatous polyposis or FAP |
| anaplasia | loss of normal shape and organization of cells and tissues associated with malignant transformation |
| anemia | reduction in the number of red blood cells, often causing fatigue |
| anorexia | loss of appetite |
| benign | non-cancerous |
| benign tumors | non-cancerous tumors |
| blood dyscrasias | an imbalance of the cellular components of the blood |
| BRCA1 | a dominant tumor suppressor gene on chromosome 17 that repairs damaged DNA. BRCA-1 mutations are found in about 7% of women with a history of breast cancer |
| BRCA-2 | a dominant tumor suppressor gene on chromosome 13 that repairs damaged DNA. BRCA-1 and 2 mutations are responsible for about 5-10% of all breast cancers |
| cachexia | general physical wasting and malnutrition associated with chronic disease |
| cancer | any neoplasm that demonstrates uncontrolled growth of abnormal cells and is associated with invasive spread and metastasis |
| carcinoma | cancers of squamous epithelial cells |
| carcinoma in situ (cis) | he earliest stage in development of carcinomas when cancer cells have not spread beyond their immediate site of origin, as when epithelial cells have not yet invaded through the basement membrane of their extracellular cell matrix |
| caretaker genes | genes that produce the proteins that repair damaged DNA |
| cellular proto-oncogenes (c-onc) | any of at least 50 different genes in the human genome such as ras that are expressed during the cell growth cycle. Cancer of a cell is usually the result of multiple mutations in c-onc genes. |
| differentiation | the process of anatomic and functional maturation demonstrated by normal cells and tissues. Progressively more undifferentiated malignancies are more primitive, under less genetic regulatory control, and are more aggressive |
| ductal carcinoma in situ (DCIS) | the pre-invasive stage of breast duct cell cancer |
| dysplasia | abnormally appearing cells usually of squamous epithelium considered to be a pre-malignant change |
| erythrocytes | red blood cells |
| familial adenomatous polyposis (FAP) | a familial form of colon cancer caused by mutations of the APC gene, characterized by development of thousands of polyps of the colon resulting in colon cancer before the third or fourth decade of life |
| five-year survival | the customary method of describing prognosis as the percent likelihood that an individual with a cancer of a specific stage and grade will be alive in five years |
| hereditary non-polyposis colon cancer (HNPCC) ("Lynch syndrome") | colon cancer associated with mutations of any of five different genes on chromosomes 2, 3, and 7 that comprise 5-15 % of all cases of colon cancer |
| homologous replication | DNA repair accomplished by certain caretaker genes by copying the correct (non-mutated) nucleotide(s) from another homologous strand, either on the other chromosome, a sister chromatid, or homologous repeat sequences on the same chromosome |
| HPC1 | a mutated dominant gene on chromosome 1 associated with familial prostate cancer that increases the risk of developing cancer before 55 years of age |
| hyperplasia | increased proliferation of cells with normal appearance in tissue often involving glandular epithelium and considered a pre-malignant change |
| leucopenia | reduction in the number of white blood cells that may cause decreased immune responsiveness, including reduced resistance to infection |
| leukemia | cancer of the white blood cells that may be chronic or acute and is named for the type of white blood cell most prominently involved |
| lymphoma | cancer of the lymphoid tissue |
| malignancy | cancer |
| malignant tumors | cancerous tumors |
| mesothelioma | malignancy of the pleura, or fibrous covering of the lung, constituting about 5% of all forms of lung cancer |
| metastasis | transfer of any disease causing agent from one part of the body to another associated with the development of the same pathologic changes in the new location |
| mitotic index | the number of cells within a microscopic field that are undergoing mitosis; a high mitotic index is associated with more rapid cell proliferation and, usually a more virulent malignancy |
| neoplasm | a new growth of tissue that serves no physiologic purpose; a tumor |
| oncogenes | genes that are uncontrollably activated by mutations or loss of control by regulator genes, leading to malignant transformation |
| oncogenesis | the induction or formation of tumors |
| oncology | the medical discipline that studies and treats various forms of cancer |
| p53 | a gene on chromosome 17 that produces a protein that suppresses cell division and/or induces cellular apoptosis. Mutations of p53 are associated with 60% of lung cancers and more rapid progression of cancers of bladder, brain, breast, cervix, gastrointest |
| pleura | the connective tissue covering of the lung |
| prostate specific antigen (PSA) | an enzyme secreted by the epithelial cells of the prostate gland that is used as a screening test for prostate cancer |
| ras | a gene on chromosome 11 that produces a signaling enzyme that activates other genes initiating mitosis. Mutations in ras irreversibly switch on mitosis. Ras mutations are present in 30% of cancers and are associated with cancers of the colon, lung, and pa |
| sarcoma | cancers of cells of mesodermal origin such as muscle or bone |
| tamoxifen | a drug that modulates estrogen receptors used to treat estrogen receptor-positive cancers |
| thrombocytopenia | reduction in the number of thrombocytes or platelets associated with uncontrolled bleeding due to impaired coagulation of blood |
| tumor grade | a clinical system to classify the degree of anaplasia of a cancer. Higher grades mean that the cancer is more undifferentiated and this is associated with higher virulence and a poorer prognosis |
| tumor necrosis factor alpha (TNF-α) | a cytokine produced by monocytes and macrophages that mediates a variety of inflammatory responses including activation of IL-1, initiation of apoptosis, and some forms of tumor cell destruction. TNF-α is also associated with cachexia. |
| tumor stage | a clinical system to classify the extent of cancer spread. Higher stages mean more extensive spread and are associated with a poorer prognosis |
Created by:
kvp
Popular Biology sets